Oaktree Acquisition Corp. III Life Sciences (OACC) Cash & Equivalents (2025)

Oaktree Acquisition Corp. III Life Sciences filings provide 1 years of Cash & Equivalents readings, the most recent being $1.4 million for Q2 2025.